UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 161

Sortiert nach

Protective and Harmful Immunity to RSV Infection

Annual review of immunology, 2017-04, Vol.35, p.501

2017

Volltextzugriff (PDF)

Natural killer cell NKG2D and granzyme B are critical for allergic pulmonary inflammation

Journal of allergy and clinical immunology, 2014-03, Vol.133 (3), p.827-835.e3

2014

Volltextzugriff (PDF)

Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses

Trends in microbiology (Regular ed.), 2021-07, Vol.29 (7), p.648-662

2021

Volltextzugriff (PDF)

Nosocomial pandemic (H1N1) 2009, United Kingdom, 2009-2010

Emerging infectious diseases, 2011-04, Vol.17 (4), p.592-598

2011

Volltextzugriff (PDF)

Increased nasal mucosal interferon and CCL13 response to a TLR7/8 agonist in asthma and allergic rhinitis

Journal of allergy and clinical immunology, 2021-02, Vol.147 (2), p.694-703.e12

2021

Volltextzugriff (PDF)

Circulating histones play a central role in COVID-19-associated coagulopathy and mortality

Haematologica (Roma), 2021-09, Vol.106 (9), p.2493

2021

Volltextzugriff (PDF)

Using imaging to combat a pandemic: rationale for developing the UK National COVID-19 Chest Imaging Database

The European respiratory journal, 2020-08, Vol.56 (2), p.2001809

2020

Volltextzugriff (PDF)

Corticosteroid Use in Otolaryngology: Current Considerations During the COVID-19 Era

Otolaryngology-head and neck surgery, 2022-11, Vol.167 (5), p.803-820

2022

Volltextzugriff (PDF)

RSV-Induced Bronchial Epithelial Cell PD-L1 Expression Inhibits CD8⁺ T Cell Nonspecific Antiviral Activity

The Journal of infectious diseases, 2011-01, Vol.203 (1), p.85-94

2011

Volltextzugriff (PDF)

The role of public involvement in the design of the first SARS-CoV-2 human challenge study during an evolving pandemic

Epidemics, 2022-12, Vol.41, p.100626-100626, Article 100626

2022

Volltextzugriff (PDF)

A gene expression signature for RSV: clinical implications and limitations

PLoS medicine, 2013-11, Vol.10 (11), p.e1001550-e1001550

Openshaw, Peter J M

2013

Volltextzugriff (PDF)

Benefit and harm from immunity to respiratory syncytial virus: implications for treatment

Current opinion in infectious diseases, 2012-12, Vol.25 (6), p.687-694

2012

Volltextzugriff (PDF)

Vaccines in the Prevention of Viral Pneumonia

Clinics in chest medicine, 2017-03, Vol.38 (1), p.155-169

2017

Volltextzugriff (PDF)

Activation of the Complement, Coagulation and Fibrinolysis Pathways after Nasal Allergen Challenge

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB384-AB384

2017

Volltextzugriff (PDF)

COVID‐19: Lessons from SARS and MERS

European journal of immunology, 2020-03, Vol.50 (3), p.308-311

2020

Volltextzugriff (PDF)

Flow cytometric measurement of intracellular cytokines

Journal of immunological methods, 2000-09, Vol.243 (1), p.107-124

2000

Volltextzugriff (PDF)

The Effect of Vitamin D Supplementation on Mucosal IL-5, MMP9 and Cathelicidin after Nasal Allergen Challenge with Grass Pollen

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB73-AB73

2016

Volltextzugriff (PDF)

Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Nature immunology, 2020-11, Vol.21 (11), p.1336

2020

Volltextzugriff (PDF)

Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e2095-e2106

2021

Volltextzugriff (PDF)

SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses

The Lancet (British edition), 2022-04, Vol.399 (10334), p.1463-1464

2022

Volltextzugriff (PDF)

Long COVID: clues about causes

The European respiratory journal, 2023-05, Vol.61 (5), p.2300409

2023

Volltextzugriff (PDF)

Using correlates to accelerate vaccinology

Science (American Association for the Advancement of Science), 2022-01, Vol.375 (6576), p.22-23

Openshaw, Peter J M

2022

Volltextzugriff (PDF)

Seasonal and pandemic influenza: 100 years of progress, still much to learn

Mucosal immunology, 2020-07, Vol.13 (4), p.566-573

2020

Volltextzugriff (PDF)

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(147)

Publikationsform

Artikel
(160)
Buchkapitel
(1)

Sprache

Englisch
(161)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(142)
Life Sciences & Biomedicine
(126)
Humans
(102)
Animals
(64)
Immunology
(62)
Respiratory Syncytial Virus
(55)
Mice
(53)
Respiratory Syncytial Virus Infections - Immunology
(48)
Female
(42)
Covid-19
(38)
Sars-Cov-2
(37)
Mice, Inbred Balb C
(33)
Microbiology
(30)
Infections
(29)
Infectious Diseases
(28)
Biological And Medical Sciences
(27)
Virology
(27)
Pandemics
(25)
Respiratory Syncytial Viruses - Immunology
(24)
Fundamental And Applied Biological Sciences. Psychology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Protective and Harmful Immunity to RSV Infection

Natural killer cell NKG2D and granzyme B are critical for allergic pulmonary inflammation

Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses

Nosocomial pandemic (H1N1) 2009, United Kingdom, 2009-2010

Increased nasal mucosal interferon and CCL13 response to a TLR7/8 agonist in asthma and allergic rhinitis

Circulating histones play a central role in COVID-19-associated coagulopathy and mortality

Using imaging to combat a pandemic: rationale for developing the UK National COVID-19 Chest Imaging Database

Corticosteroid Use in Otolaryngology: Current Considerations During the COVID-19 Era

RSV-Induced Bronchial Epithelial Cell PD-L1 Expression Inhibits CD8⁺ T Cell Nonspecific Antiviral Activity

The role of public involvement in the design of the first SARS-CoV-2 human challenge study during an evolving pandemic

A gene expression signature for RSV: clinical implications and limitations

Benefit and harm from immunity to respiratory syncytial virus: implications for treatment

Vaccines in the Prevention of Viral Pneumonia

Activation of the Complement, Coagulation and Fibrinolysis Pathways after Nasal Allergen Challenge

COVID‐19: Lessons from SARS and MERS

Flow cytometric measurement of intracellular cytokines

The Effect of Vitamin D Supplementation on Mucosal IL-5, MMP9 and Cathelicidin after Nasal Allergen Challenge with Grass Pollen

Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study

SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses

Long COVID: clues about causes

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study

Using correlates to accelerate vaccinology

Seasonal and pandemic influenza: 100 years of progress, still much to learn

Suchergebnisse filtern